SIREN : 819247065
AMW HEALTH INVESTMENT is a French company founded 10 years ago, specialized in the sector Gestion de fonds. Based in LE MESNIL-SAINT-DENIS (78320), this company of category PME shows in 2024 a revenue of 791 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Kennzahl | 2024 | 2023 | 2022 | 2019 | 2018 | 2016 |
|---|---|---|---|---|---|---|
| Umsatz | 791 294 € | N/C | N/C | N/C | N/C | N/C |
| Nettoergebnis | 748 562 € | 1 263 061 € | 1 661 437 € | 76 451 € | -3 953 € | -2 240 € |
| EBITDA | -93 448 € | N/C | N/C | -3 699 € | -3 953 € | -2 240 € |
| Nettomarge | 94.6% | N/C | N/C | N/C | N/C | N/C |
In 2024, AMW HEALTH INVESTMENT achieves revenue of 791 k€. After deducting consumption (0 €), gross margin stands at 791 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -93 k€, representing -11.8% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 749 k€, i.e. 94.6% of revenue. This profit can be retained or distributed to shareholders.
791 294 €
791 294 €
-93 448 €
-59 567 €
748 562 €
-11.8%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 93%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 84.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
1.361%
92.936%
84.478%
0.09
86.9%
In 2024, the debt ratio of AMW HEALTH INVESTMENT (1.36) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of AMW HEALTH INVESTMENT (92.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of AMW HEALTH INVESTMENT (0.09) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 111.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
111.383
-0.342
In 2024, the liquidity ratio of AMW HEALTH INVESTMENT (111.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of AMW HEALTH INVESTMENT (-0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 79 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 26 days. The gap of 53 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 34 days of revenue, i.e. 75 k€ to permanently finance.
75 466 €
79 j
26 j
0 j
34 j
Based on 62 transactions of similar company sales
in 2024,
the value of AMW HEALTH INVESTMENT is estimated at
2 357 653 €
(range 703 145€ - 4 786 861€).
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare AMW HEALTH INVESTMENT with other companies in the same sector:
The revenue of AMW HEALTH INVESTMENT in 2024 is 791 k€.
Yes, AMW HEALTH INVESTMENT generated a net profit of 749 k€ in 2024.
The headquarters of AMW HEALTH INVESTMENT is located in LE MESNIL-SAINT-DENIS (78320), in the department Yvelines.
The tax return of AMW HEALTH INVESTMENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
AMW HEALTH INVESTMENT operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.